Among them, cytokine assay was conducted in 41 patients who had peripheral blood samples both at baseline and during treatment with PD-1/PD-L1 blockade, including 21 patients with cachexia (51.2%) and 20 non-cachectic patients (48.8%) (Figure S1). This evidence concerns the gene CD274 and Cachexia.